Join the Releuko group to help and get support from people like you.
Releuko News
Updated FDA Labeling Recommendations for Biosimilar and Interchangeable Biosimilar Products
October 26, 2023 – Over the last eight years, FDA has approved more than 40 biosimilar products (biosimilars), and they have become an important treatment option for health care professionals and...
FDA Approves Releuko (filgrastim-ayow), a Biosimilar to Neupogen
PISCATAWAY, N.J.--(BUSINESS WIRE)-- March 2, 2022 Kashiv Biosciences, LLC (“Kashiv”) today announced the U.S. Food and Drug Administration (FDA) approval of its Biologics License Application (BLA) for...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Neutropenia Associated with Chemotherapy